Explore All Access
Check if your research matches the topics covered in Anti-Obesity Drug Discovery and Development?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Anti-Obesity Drug Discovery and Development : Impact Factor & More
eISSN: 2210-2698pISSN: 2467-9615
Share this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Anti-Obesity Drug Discovery and Development Key Metrics
CiteScore 
0.1
Anti-Obesity Drug Discovery and Development Journal Specifications
| Overview | |
| Publisher | Bentham |
One subscription packed with expert publication services and AI tools to get you published
Brought to you by 
Journal Selection Service
Benefit from our experts' recommendations of 3-5 best-suited journals, accompanied by a detailed Journal Selection report explaining the choices. Make informed decisions.
Journal Submission Service
Streamline your submission process with meticulous manuscript formatting to meet journal guidelines, crafting a tailored cover letter for the editor, and hassle-free account creation and submission
Bundle of AI tools for your research needs
Journal Finder, Paperpal, R Discovery, MindTheGraph and more
Planning to publish in Anti-Obesity Drug Discovery and Development ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
FAQs on Anti-Obesity Drug Discovery and Development
What is the eISSN & pISSN for Anti-Obesity Drug Discovery and Development? 
For Anti-Obesity Drug Discovery and Development, eISSN is 2210-2698 and pISSN is 2467-9615.
What is Citescore for Anti-Obesity Drug Discovery and Development?
Citescore for Anti-Obesity Drug Discovery and Development is 0.1.
Who is the publisher of Anti-Obesity Drug Discovery and Development?
Bentham is the publisher of Anti-Obesity Drug Discovery and Development.